Journal Of Cosmetic Dermatology Publishes Data Demonstrating Patient Satisfaction With Natural-Looking Outcomes Following Treatment With OnabotulinumtoxinA (BOTOX Cosmetic)
Portfolio Pulse from Happy Mohamed
Allergan Aesthetics, an AbbVie company, announced that the Journal of Cosmetic Dermatology published results from a year-long study evaluating the impact of BOTOX Cosmetic on upper facial lines in adults. The study found that 90.5% of patients were satisfied with a natural look 30 days after treatment, and this satisfaction was sustained by over 80% of patients throughout the 12-month study period.
August 30, 2023 | 1:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The positive results from the study on BOTOX Cosmetic, a product of Allergan Aesthetics, an AbbVie company, could potentially boost the company's reputation and sales in the short term.
The study results demonstrate high patient satisfaction with BOTOX Cosmetic, which could lead to increased demand for the product. This could potentially boost AbbVie's sales and stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100